Apogee Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
APGE Nasdaq 2830 www.apogeetherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apogee Therapeutics, Inc.

Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing - Mar 4th, 2026 9:11 am
Apogee Therapeutics Teases 52-Week Zumi Durability Data, Phase III Path at TD Cowen Conference - Mar 4th, 2026 4:34 am
Is Rising R&D Spend And New Equity Shelf Altering The Investment Case For Apogee Therapeutics (APGE)? - Mar 3rd, 2026 8:11 pm
Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results - Mar 2nd, 2026 5:00 am
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million - Feb 25th, 2026 1:26 pm
This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges - Feb 25th, 2026 1:19 pm
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst - Feb 25th, 2026 1:11 pm
Apogee Therapeutics to Participate in Upcoming March Conferences - Feb 24th, 2026 5:30 am
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million - Feb 22nd, 2026 12:36 pm
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction - Feb 22nd, 2026 12:16 pm
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges - Feb 22nd, 2026 11:56 am
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations - Feb 18th, 2026 5:39 pm
Is Apogee Therapeutics (APGE) Now Defined by Its IL-13/OX40L Positioning Against Sanofi? - Feb 16th, 2026 4:10 pm
Here is Why Apogee Therapeutics (APGE) Appears Attractive - Feb 16th, 2026 11:03 am
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress - Feb 14th, 2026 9:18 am
Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million - Feb 14th, 2026 9:07 am
Apogee Therapeutics touts quarterly-to-biannual AD dosing shift, expands asthma ambitions at conference - Feb 12th, 2026 7:07 pm
Apogee Therapeutics to Participate at the Guggenheim Emerging Outlook: Biotech Summit 2026 - Feb 5th, 2026 6:00 am
Elastic NV, Acadia Healthcare, and More Stocks See Action From Activist Investors - Jan 30th, 2026 5:39 pm
Funding for Risky Biotechs Is Returning - Jan 12th, 2026 10:00 am